Skip to main content
Clinical Trials/KCT0005913
KCT0005913
Not Yet Recruiting
N/A

A human study for evaluating effectiveness and safety of GPX on gut immunity

Ewha Womens University0 sites116 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diseases of the digestive system
Sponsor
Ewha Womens University
Enrollment
116
Status
Not Yet Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Ewha Womens University

Eligibility Criteria

Inclusion Criteria

  • 1\) Subject who voluntarily agree to participate and signs informed consent form
  • 2\) Age more than 20\-year\-old and less than 65 years old
  • 3\) BMI \= 23 kg/m2
  • 4\) Subject with a waist circumference of Male \= 90 cm, Female \= 85 cm
  • 5\) Subject who has had diarrhea or constipation symptoms at least once a week in the past month

Exclusion Criteria

  • 1\) Subjects with the following diseases:
  • \- Intestinal diseases (Crohn's disease, colon cancer, celiac disease, inflammatory bowel disease IBD, etc.)
  • \- Patients with a history of lactose intolerance, gastrointestinal surgery (gastrointestinal duct surgery, etc.)
  • \- Thyroid disease, multiple sclerosis, spinal trauma, Cushing's syndrome, hyperlipidemia, cerebrovascular disease, cardiovascular disease, etc.
  • \- Severe central nervous system disorders requiring hospitalization or medication (dementia, Parkinson's disease, etc.)
  • 2\) Those who fall under the following
  • \- Consistent intake of antibiotics for more than a week within 4 weeks before the first visit
  • \- Temporarily took nonsteroidal anti\-inflammatory drugs, corticosteroids, an immunosuppressive drug, etc. within 2 weeks before the first visit, or continuously took the drug within 12 weeks of before the first visit.
  • \- Antibacterial treatment within 6 weeks before the first visit.
  • \- Ingestion of appetite suppressants/stimulants, antidepressants, diuretics/beta\-blockers, contraceptives, hormone drugs, etc. within 4 weeks before the first visit

Outcomes

Primary Outcomes

Not specified

Similar Trials